Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Dec. 25 at 5:09 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 25 at 4:23 PM
$RADX Misinformation 👇
0 · Reply
viking1111
viking1111 Dec. 25 at 2:18 PM
$RADX we see many posts on this board and others about shorting, as if that is a main reason a particular stock trades where it does and isn't trading higher. Imo dilution is what keeps stocks down and inst shorts go along for the ride. They know it works in their favor. If a co turns the corner becomes profitable and stops needing to constantly dilute then they can move up. The gern board is another good example of this. Constant talk about the 77 mil short int instead of the prior financing deals that ballooned the float to over 600 mil and a pps in the 1.30's after yrs of being in existence.
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 25 at 1:42 PM
670% $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 25 at 1:23 PM
$RADX Merry Christmas 🎁🎄
0 · Reply
EfficiencyEdge
EfficiencyEdge Dec. 25 at 8:23 AM
$RADX The valuation debate now centers on reliability of delivery, while valuation increasingly tracks execution consistency. Momentum turns durable only after multiple confirmations.
1 · Reply
biospeculator
biospeculator Dec. 24 at 7:10 PM
$RADX Quick thoughts on the recent announcement of the ATM for up to $25M in US ADR's. This is an efficient way to raise capital vs. a secondary option. Previously, capital was raised from LNTH and the recent offering. IMO this ATM will be used upon upcoming news. With both Her2 and RAD 101 results due first half of 2026, we get 2 bites at the apple. My only question is how that affects the possibility of selling RAD101 upon completion of the phase II trial? GLTA
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 6:46 PM
$RADX Thanks Lucky for bringing us a lot of Luck.🍀
0 · Reply
Chief84
Chief84 Dec. 24 at 5:58 PM
$RADX expecting this to be a huge runner going into new year 🤞
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 4:57 PM
$RADX Borrow rate 1000%
2 · Reply
Latest News on RADX
Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Dec 15, 2025, 11:59 AM EST - 10 days ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Dec 15, 2025, 7:00 AM EST - 10 days ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Oct 20, 2025, 7:30 AM EDT - 2 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Radiopharm Theranostics Limited - Special Call

Sep 2, 2025, 1:15 AM EDT - 4 months ago

Radiopharm Theranostics Limited - Special Call

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Jul 29, 2025, 7:30 AM EDT - 5 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Jul 22, 2025, 8:00 AM EDT - 5 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Jun 2, 2025, 8:00 AM EDT - 7 months ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

May 19, 2025, 8:00 AM EDT - 7 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Dec 30, 2024, 8:00 AM EST - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Dec 20, 2024, 8:00 AM EST - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Sep 19, 2024, 12:00 PM EDT - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

DB

RadioIsotope25
RadioIsotope25 Dec. 25 at 5:09 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 25 at 4:23 PM
$RADX Misinformation 👇
0 · Reply
viking1111
viking1111 Dec. 25 at 2:18 PM
$RADX we see many posts on this board and others about shorting, as if that is a main reason a particular stock trades where it does and isn't trading higher. Imo dilution is what keeps stocks down and inst shorts go along for the ride. They know it works in their favor. If a co turns the corner becomes profitable and stops needing to constantly dilute then they can move up. The gern board is another good example of this. Constant talk about the 77 mil short int instead of the prior financing deals that ballooned the float to over 600 mil and a pps in the 1.30's after yrs of being in existence.
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 25 at 1:42 PM
670% $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 25 at 1:23 PM
$RADX Merry Christmas 🎁🎄
0 · Reply
EfficiencyEdge
EfficiencyEdge Dec. 25 at 8:23 AM
$RADX The valuation debate now centers on reliability of delivery, while valuation increasingly tracks execution consistency. Momentum turns durable only after multiple confirmations.
1 · Reply
biospeculator
biospeculator Dec. 24 at 7:10 PM
$RADX Quick thoughts on the recent announcement of the ATM for up to $25M in US ADR's. This is an efficient way to raise capital vs. a secondary option. Previously, capital was raised from LNTH and the recent offering. IMO this ATM will be used upon upcoming news. With both Her2 and RAD 101 results due first half of 2026, we get 2 bites at the apple. My only question is how that affects the possibility of selling RAD101 upon completion of the phase II trial? GLTA
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 6:46 PM
$RADX Thanks Lucky for bringing us a lot of Luck.🍀
0 · Reply
Chief84
Chief84 Dec. 24 at 5:58 PM
$RADX expecting this to be a huge runner going into new year 🤞
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 4:57 PM
$RADX Borrow rate 1000%
2 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 4:26 PM
$RADX If management has attracted funds each can easily buy 100,000 to 500,000 shares
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 3:58 PM
$RADX Someone’s buying everything. Don’t be shy sell your lot. Investors are happy to own it.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 2:51 PM
$RADX Aktis Pipeline is thin for $1.4 billion valuation. RAD already has a phase 1 Ind approved B7-h3 therapeutic.. I guess they are getting the HALO effect. Anyways just shines a light on RADX and how undervalued it is.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 24 at 1:01 AM
When Aktis Oncology goes public in first quarter their market cap will be over a billion. They have 1 radiopharmaceutical in Phase 1 and a second preclinical for B7-H3.. Have over 132 million shares so if they issue $100 million at $10 we’re talking $1.4 billion market cap. Considering Radiopharm Theranostics has market cap of $66 million it would have 24x upside to reach their newly minted market cap. So what they have a deal with Lilly. $RADX has been getting money from $LNTH and and MD Anderson through Radiopharm Ventures. There using microproteins and RAD is using nanobodies. Plus RAD has a $500 million imaging agent in an unmet medical need. Rad is a no brainer with over a handful of clinical assets. $CATX
2 · Reply
viking1111
viking1111 Dec. 23 at 9:51 PM
$RADX better candle today than yesterday. We'll see if it holds soon enough.
0 · Reply
jdkd4
jdkd4 Dec. 23 at 8:16 PM
$RADX holding
3 · Reply
RadioIsotope25
RadioIsotope25 Dec. 23 at 7:55 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 23 at 5:47 PM
$RADX $10 stock here. 2 for price of 1 blue light special
1 · Reply
Ontherag
Ontherag Dec. 23 at 5:27 PM
$RADX Rad101 full readout q2 2026. We already know the data is going to be blockbuster.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 23 at 5:20 PM
$RADX Potential vacuum between $6.40 and $10.40. Never traded in that range.
0 · Reply
Chief84
Chief84 Dec. 23 at 5:16 PM
$RADX
0 · Reply
buzz23
buzz23 Dec. 23 at 4:55 PM
$RADX do we have any clue what the short interest is at this point? Even with the high cost to borrow my shares aren't being lent out on Etrade, which I find odd if it's so hard to borrow.
0 · Reply